rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2000-9-27
|
pubmed:abstractText |
The purpose of this study was to determine whether lowering homocysteine levels with folic acid, with or without antioxidants, will improve endothelial dysfunction in patients with coronary artery disease (CAD).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0735-1097
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
758-65
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10987596-Aged,
pubmed-meshheading:10987596-Antioxidants,
pubmed-meshheading:10987596-Ascorbic Acid,
pubmed-meshheading:10987596-Blood Circulation,
pubmed-meshheading:10987596-Coronary Disease,
pubmed-meshheading:10987596-Double-Blind Method,
pubmed-meshheading:10987596-Endothelium, Vascular,
pubmed-meshheading:10987596-Female,
pubmed-meshheading:10987596-Folic Acid,
pubmed-meshheading:10987596-Homocysteine,
pubmed-meshheading:10987596-Humans,
pubmed-meshheading:10987596-Lipids,
pubmed-meshheading:10987596-Male,
pubmed-meshheading:10987596-Malondialdehyde,
pubmed-meshheading:10987596-Middle Aged,
pubmed-meshheading:10987596-Nitroglycerin,
pubmed-meshheading:10987596-Vasodilation,
pubmed-meshheading:10987596-Vasodilator Agents,
pubmed-meshheading:10987596-Vitamin B 12,
pubmed-meshheading:10987596-Vitamin E
|
pubmed:year |
2000
|
pubmed:articleTitle |
Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease.
|
pubmed:affiliation |
Division of Cardiology, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada. ltitle@is.dal.ca
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|